{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T02:00:39Z","timestamp":1774663239055,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.lfs.2019.116930","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T01:52:04Z","timestamp":1570758724000},"page":"116930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["The potent immunomodulatory compound VGX-1027 regulates inflammatory mediators in CD4+ T cells, which are concomitant with the prevention of neuroimmune dysregulation in BTBR T+ Itpr3tf\/J mice"],"prefix":"10.1016","volume":"237","author":[{"given":"Sheikh F.","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mushtaq A.","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleh A.","family":"Bakheet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawaz","family":"Alasmari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah F.","family":"Alasmari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Layla A.","family":"Al-Kharashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.H.","family":"Al-Qahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabry M.","family":"Attia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2019.116930_bib1","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association (APA)","year":"2015"},{"key":"10.1016\/j.lfs.2019.116930_bib2","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00213-013-3290-7","article-title":"Biomarkers in autism spectrum disorder: the old and the new","volume":"231","author":"Ruggeri","year":"2014","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.lfs.2019.116930_bib3","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jneuroim.2010.10.025","article-title":"Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders","volume":"232","author":"Ashwood","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.lfs.2019.116930_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.imlet.2014.11.006","article-title":"Evidence supporting an altered immune response in ASD","volume":"163","author":"Mead","year":"2015","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.lfs.2019.116930_bib5","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.20315","article-title":"Neuroglial activation and neuroinflammation in the brain of patients with autism","volume":"57","author":"Vargas","year":"2005","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.lfs.2019.116930_bib6","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1007\/s12035-016-9977-0","article-title":"Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism","volume":"54","author":"Ahmad","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.lfs.2019.116930_bib7","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1007\/s12035-016-0066-1","article-title":"Resveratrol ameliorates dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in a BTBR T+ tf\/J mouse model of autism","volume":"54","author":"Bakheet","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2019.116930_bib8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mcn.2012.10.002","article-title":"The role of the innate immune system in psychiatric disorders","volume":"53","author":"Jones","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.lfs.2019.116930_bib9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1196\/annals.1381.013","article-title":"Cytokine levels during pregnancy influence immunological profiles and neurobehavioral patterns of the offspring","volume":"1107","author":"Ponzio","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.lfs.2019.116930_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuron.2009.09.002","article-title":"Cytokines and CNS development","volume":"64","author":"Deverman","year":"2009","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.lfs.2019.116930_bib11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/mp.2016.77","article-title":"Autism with intellectual disability is associated with increased levels of maternal cytokines and chemokines during gestation","volume":"22","author":"Jones","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.lfs.2019.116930_bib12","doi-asserted-by":"crossref","first-page":"10695","DOI":"10.1523\/JNEUROSCI.2178-07.2007","article-title":"Maternal immune activation alters fetal brain development through interleukin-6","volume":"27","author":"Smith","year":"2007","journal-title":"J. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2019.116930_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneuroim.2008.12.002","article-title":"Elevated immune response in the brain of autistic patients","volume":"207","author":"Li","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.lfs.2019.116930_bib14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.biopsych.2010.05.024","article-title":"Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism","volume":"68","author":"Morgan","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.lfs.2019.116930_bib15","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1309\/AJCP7UBK8IBVMVNR","article-title":"Analysis of proinflammatory and anti-inflammatory cytokine serum concentrations in patients with multiple sclerosis by using a multiplexed immunoassay","volume":"136","author":"Martins","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.lfs.2019.116930_bib16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/0748233711427048","article-title":"Mercury induces the expression of cyclooxygenase-2 and inducible nitric oxide synthase","volume":"2","author":"Park","year":"2013","journal-title":"Toxicol. Ind. Health"},{"key":"10.1016\/j.lfs.2019.116930_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fpsyt.2011.00027","article-title":"Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammation","volume":"2","author":"Young","year":"2011","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.lfs.2019.116930_bib18","first-page":"785265","article-title":"NF-\u03baB signaling in the brain of autistic subjects","author":"Malik","year":"2011","journal-title":"Mediat. Inflamm."},{"issue":"6","key":"10.1016\/j.lfs.2019.116930_bib19","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1471-4159.2004.02829.x","article-title":"Prostaglandin E2 and microsomal prostaglandin E synthase-2 expression are decreased in the cyclooxygenase-2-deficient mouse brain despite compensatory induction of cyclooxygenase-1 and Ca2+-dependent phospholipase A2","volume":"91","author":"Bosetti","year":"2004","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.lfs.2019.116930_bib20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1073\/pnas.1517642113","article-title":"Systematic study of constitutive cyclooxygenase-2 expression: role of NF-kappaB and NFAT transcriptional pathways","volume":"113","author":"Kirkby","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.lfs.2019.116930_bib21","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.bbamcr.2014.04.016","article-title":"The dual face of connexin-based astroglial Ca(21) communication: a key player in brain physiology and a prime target in pathology","volume":"1843","author":"De Bock","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.lfs.2019.116930_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12017-018-8483-0","article-title":"Resveratrol improves neuroimmune dysregulation through the inhibition of neuronal toll-like receptors and COX-2 signaling in BTBR T+ Itpr3tf\/J mice","volume":"20","author":"Ahmad","year":"2018","journal-title":"NeuroMolecular Med."},{"issue":"1","key":"10.1016\/j.lfs.2019.116930_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cyto.2014.10.031","article-title":"Interleukin-10 paradox: a potent immunoregulatory cytokine that has been difficult to harness for immunotherapy","volume":"74","author":"Saxena","year":"2015","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.lfs.2019.116930_bib24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cytogfr.2010.09.002","article-title":"Biology of interleukin-10","volume":"21","author":"Sabat","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.lfs.2019.116930_bib25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12974-016-0763-8","article-title":"Balancing the immune response in the brain: IL-10 and its regulation","volume":"13","author":"Lobo-Silva","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"9","key":"10.1016\/j.lfs.2019.116930_bib26","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1523\/JNEUROSCI.16-09-02945.1996","article-title":"Attenuation of astroglial reactivity by interleukin-10","volume":"16","author":"Balasingam","year":"1996","journal-title":"J. Neurosci."},{"issue":"Pt A","key":"10.1016\/j.lfs.2019.116930_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neuropharm.2014.10.020","article-title":"The therapeutic potential of interleukin-10 in neuroimmune diseases","volume":"96","author":"Kwilasz","year":"2015","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.lfs.2019.116930_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/glia.22581","article-title":"High mobility group box protein-1 promotes cerebral edema after traumatic brain injury via activation of toll-like receptor 4","volume":"62","author":"Laird","year":"2014","journal-title":"Glia"},{"issue":"5","key":"10.1016\/j.lfs.2019.116930_bib29","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/bjp.2008.315","article-title":"Effects of the immunomodulator, VGX-1027, in endotoxin-induced uveitis in Lewis rats","volume":"155","author":"Mangano","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2019.116930_bib30","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1601-183X.2007.00330.x","article-title":"Autism-like behavioral phenotypes in BTBR T\u00fetf\/J mice","volume":"7","author":"McFarlane","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.lfs.2019.116930_bib31","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/npp.2009.201","article-title":"Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP","volume":"35","author":"Silverman","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.lfs.2019.116930_bib32","doi-asserted-by":"crossref","first-page":"e20912","DOI":"10.1371\/journal.pone.0020912","article-title":"Aberrant immune responses in a mouse with behavioral disorders","volume":"6","author":"Heo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2019.116930_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbi.2014.06.006","article-title":"Inflammatory profiles in the BTBR mouse: how relevant are they to autism spectrum disorders?","volume":"43","author":"Careaga","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.lfs.2019.116930_bib34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbi.2016.12.024","article-title":"Toll-like receptor 4 signaling is associated with upregulated NADPH oxidase expression in peripheral T cells of children with autism","volume":"61","author":"Nadeem","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.lfs.2019.116930_bib35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bbr.2019.02.031","article-title":"Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+tf\/J mice","volume":"364","author":"Ahmed","year":"2019","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.lfs.2019.116930_bib36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.clim.2007.03.004","article-title":"In vitro, ex vivo and in vivo immunopharmacological activities of the isoxazoline compound VGX-1027: modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models","volume":"123","author":"Stojanovic","year":"2007","journal-title":"Clin. Immunol."},{"issue":"9","key":"10.1016\/j.lfs.2019.116930_bib37","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1038\/npp.2015.66","article-title":"GABAB receptor agonist R-baclofen reverses social deficits and reduces repetitive behavior in two mouse models of autism","volume":"40","author":"Silverman","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.lfs.2019.116930_bib38","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pnpbp.2012.04.011","article-title":"Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice","volume":"38","author":"Gould","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.lfs.2019.116930_bib39","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1523\/JNEUROSCI.2010-17.2017","article-title":"Insulin-like growth factor II targets the mTOR pathway to reverse autism-like phenotypesin mice","volume":"38","author":"Steinmetz","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2019.116930_bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.molimm.2016.08.017","article-title":"The tyrosine kinase inhibitor tyrphostin AG126 reduces activation of inflammatory cells and increases Foxp3+ regulatory T cells during pathogenesis of rheumatoid arthritis","volume":"78","author":"Ahmad","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.lfs.2019.116930_bib41","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cellsig.2017.04.014","article-title":"Adenosine A2A receptor modulates neuroimmune function through Th17\/retinoid-related orphan receptor gamma t (ROR\u03b3t) signaling in a BTBR T+ Itpr3tf\/J mouse model of autism","volume":"36","author":"Ansari","year":"2017","journal-title":"Cell. Signal."},{"key":"10.1016\/j.lfs.2019.116930_bib42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.mcn.2017.04.012","article-title":"Activation of adenosine A2A receptor signaling regulates the expression of cytokines associated with immunologic dysfunction in BTBR T+ Itpr3tf\/J mice","volume":"82","author":"Ansari","year":"2017","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.lfs.2019.116930_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcn.2016.09.004","article-title":"Resveratrol treatment attenuates chemokine receptor expression in the BTBR T+tf\/J mouse model of autism","volume":"77","author":"Bakheet","year":"2016","journal-title":"Mol. Cell. Neurosci."},{"issue":"5","key":"10.1016\/j.lfs.2019.116930_bib44","first-page":"463","article-title":"Autoimmunity in autism","volume":"10","author":"Enstrom","year":"2009","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.lfs.2019.116930_bib45","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bbi.2011.08.007","article-title":"The role of immune dysfunction in the pathophysiology of autism","volume":"26","author":"Onore","year":"2012","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.lfs.2019.116930_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.1205707","article-title":"The immune response in autism: a new frontier for autism research","volume":"80","author":"Ashwood","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.lfs.2019.116930_bib47","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1038\/tp.2013.16","article-title":"Maternal immune activation and strain specific interactions in the development of autism-like behaviors in mice","volume":"3","author":"Schwartzer","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.lfs.2019.116930_bib48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jneumeth.2013.12.010","article-title":"Validation and implementation of a novel high-throughput behavioral phenotyping instrument for mice","volume":"224","author":"Brodkin","year":"2014","journal-title":"J. Neurosci. Methods"},{"issue":"2","key":"10.1016\/j.lfs.2019.116930_bib49","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1601-183X.2007.00330.x","article-title":"Autism-like behavioral phenotypes in BTBR T+ tf\/J mice","volume":"7","author":"McFarlane","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.lfs.2019.116930_bib51","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1176\/ajp.150.8.1189","article-title":"Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?","volume":"150","author":"Maes","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.lfs.2019.116930_bib52","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bbi.2010.09.002","article-title":"Altered T cell responses in children with autism","volume":"25","author":"Ashwood","year":"2011","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.lfs.2019.116930_bib53","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbi.2010.08.003","article-title":"Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome","volume":"25","author":"Ashwood","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.lfs.2019.116930_bib54","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbi.2016.05.009","article-title":"Associations between cytokines, endocrine stress response, and gastrointestinal symptoms in autism spectrum disorder","volume":"58","author":"Ferguson","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.lfs.2019.116930_bib55","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.pediatrneurol.2007.01.012","article-title":"Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children","volume":"36","author":"Chez","year":"2007","journal-title":"Pediatr. Neurol."},{"issue":"4","key":"10.1016\/j.lfs.2019.116930_bib56","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1517\/13543784.2014.998334","article-title":"Novel investigational drugs targeting IL-6 signaling for the treatment of depression","volume":"24","author":"Fonseka","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"10","key":"10.1016\/j.lfs.2019.116930_bib57","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.bbadis.2016.07.013","article-title":"Inhibition of IL-6 trans-signaling in the brain increases sociability in the BTBR mouse model of autism","volume":"1862","author":"Wei","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.lfs.2019.116930_bib58","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1113\/expphysiol.2005.030734","article-title":"Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system","volume":"90","author":"Pickering","year":"2005","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.lfs.2019.116930_bib59","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000065416","article-title":"Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder","volume":"46","author":"Jyonouchi","year":"2002","journal-title":"Neuropsychobiology"},{"issue":"1","key":"10.1016\/j.lfs.2019.116930_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000048665","article-title":"Activation of the inflammatory response system in autism","volume":"45","author":"Croonenberghs","year":"2002","journal-title":"Neuropsychobiology"},{"issue":"2","key":"10.1016\/j.lfs.2019.116930_bib61","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/sj.mp.4002042","article-title":"Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling","volume":"13","author":"Meyer","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.lfs.2019.116930_bib62","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.4049\/jimmunol.169.5.2253","article-title":"Shaping gene expression in activated and resting primary macrophages by IL-10","volume":"169","author":"Lang","year":"2002","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2019.116930_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12031-016-0847-z","article-title":"Cytokine profile in autism spectrum disorders in children","volume":"61","author":"Bryn","year":"2017","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.lfs.2019.116930_bib64","doi-asserted-by":"crossref","first-page":"e19488","DOI":"10.1371\/journal.pone.0019488","article-title":"A study of nuclear transcription factor-kappa B in childhood autism","volume":"6","author":"Naik","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2019.116930_bib65","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1517\/14728222.11.2.123","article-title":"NF-kappa B as a therapeutic target in neurodegenerative diseases","volume":"11","author":"Camandola","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"issue":"6","key":"10.1016\/j.lfs.2019.116930_bib66","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/glia.22652","article-title":"NOS2 expression is restricted to neurons in the healthy brain but is triggered in microglia upon inflammation","volume":"62","author":"B\u00e9chade","year":"2014","journal-title":"Glia"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519308574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519308574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:24:14Z","timestamp":1758399854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320519308574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":65,"alternative-id":["S0024320519308574"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.116930","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potent immunomodulatory compound VGX-1027 regulates inflammatory mediators in CD4+ T cells, which are concomitant with the prevention of neuroimmune dysregulation in BTBR T+ Itpr3tf\/J mice","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.116930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116930"}}